(Q35618437)

9 August 2017

title

Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders (English)

1 reference

9 August 2017

1 reference

Glenda Macqueen

1

1 reference

9 August 2017

Trevor Young

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

5 Suppl 2

1 reference

9 August 2017

page(s)

53-61

1 reference

Sustained attention deficit in bipolar disorder

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Sustained attention deficit in bipolar disorder is not a working memory impairment in disguise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Declarative and procedural memory in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Cognitive impairment in the euthymic phase of affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Influence of age and executive functioning on verbal memory of inpatients with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Different trait markers for schizophrenia and bipolar disorder: a neurocognitive approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

The role of working memory in visual selective attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Backward masking in bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Backward masking in schizophrenia and mania. I. Specifying a mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Cognitive impairment in remission in bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Effects of lithium carbonate on memory and other cognitive functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Effects of lithium on memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Effects of lithium carbonate on the memory and motor speed of bipolar outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

A double-blind, placebo-controlled study of the effects of lithium on cognition in healthy subjects: mild and selective effects on learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Differential cognitive and behavioral effects of carbamazepine and lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Factors associated with behavioral and cognitive abnormalities in children receiving topiramate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Effects of topiramate on cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Postmarketing experience with topiramate and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

A randomized, placebo-controlled trial of paroxetine in nursing home residents with non-major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Acute administration of citalopram facilitates memory consolidation in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Neurotrophins and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Rat fetal ventral mesencephalon grown as solid tissue cultures: influence of culture time and BDNF treatment on dopamine neuron survival and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

BDNF activated TrkB/IRR receptor chimera promotes survival of sympathetic neurons through Ras and PI-3 kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Cognitive effects and antipsychotic treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Cognitive improvement in schizophrenia with novel antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Procedural learning improvements after six weeks of clozapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Neuropsychological change in schizophrenia after 6 weeks of clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Risperidone versus haloperidol on secondary memory: can newer medications aid learning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Attentional improvement following quetiapine fumarate treatment in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Does cognitive function improve with quetiapine in comparison to haloperidol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Impaired distractor inhibition in patients with schizophrenia on a negative priming task

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Atypical neuroleptics stimulate neurogenesis in adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Regulation of adult neurogenesis by antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Working memory in schizophrenia and mania: correlation with symptoms during the acute and subacute phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Backward masking task performance in stable, euthymic out-patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Backward masking in schizophrenia and mania. II. Specifying the visual channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Impaired neuropsychological performance in euthymic patients with recurring mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Can lithium help to prevent suicide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Serum lithium levels and the outcome of maintenance therapy of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Cognitive effects of valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

Enhancement of hippocampal neurogenesis by lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00059.X

10.1111/J.1399-2406.2003.00059.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference